{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T11:48:38Z","timestamp":1793015318169,"version":"4.5.0"},"reference-count":137,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.jhep.2017.04.026","type":"journal-article","created":{"date-parts":[[2017,7,15]],"date-time":"2017-07-15T01:15:22Z","timestamp":1500081322000},"page":"619-631","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":182,"title":["Biliary bile acids in hepatobiliary injury \u2013 What is the link?"],"prefix":"10.1016","volume":"67","author":[{"given":"Peter","family":"Fickert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2017.04.026_b0005","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1002\/cphy.c120027","article-title":"Bile formation and secretion","volume":"3","author":"Boyer","year":"2013","journal-title":"Compr Physiol"},{"key":"10.1016\/j.jhep.2017.04.026_b0010","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev.biochem.72.121801.161712","article-title":"The enzymes, regulation, and genetics of bile acid synthesis","volume":"72","author":"Russell","year":"2003","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.jhep.2017.04.026_b0015","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2174\/156652407780059168","article-title":"Enzymes in the conversion of cholesterol into bile acids","volume":"7","author":"Norlin","year":"2007","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.jhep.2017.04.026_b0020","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1194\/jlr.R000042","article-title":"Bile salts of vertebrates: structural variation and possible evolutionary significance","volume":"51","author":"Hofmann","year":"2010","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jhep.2017.04.026_b0025","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1101\/gad.184788.111","article-title":"Endocrine fibroblast growth factors 15\/19 and 21: from feast to famine","volume":"26","author":"Potthoff","year":"2012","journal-title":"Genes Dev"},{"key":"10.1016\/j.jhep.2017.04.026_b0030","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cmet.2016.05.005","article-title":"Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism","volume":"24","author":"Wahlstrom","year":"2016","journal-title":"Cell Metab"},{"key":"10.1016\/j.jhep.2017.04.026_b0035","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.jhep.2015.02.023","article-title":"New paradigms in the treatment of hepatic cholestasis: from UDCA to FXR, PXR and beyond","volume":"62","author":"Beuers","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2017.04.026_b0040","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1056\/NEJMoa1509840","article-title":"A placebo-controlled trial of obeticholic acid in primary biliary cholangitis","volume":"375","author":"Nevens","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2017.04.026_b0045","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1053\/jhep.2002.36088","article-title":"Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited","volume":"36","author":"Paumgartner","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2017.04.026_b0050","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.mayocp.2015.03.017","article-title":"The cholangiopathies","volume":"90","author":"Lazaridis","year":"2015","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jhep.2017.04.026_b0055","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1172\/JCI4765","article-title":"Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas","volume":"103","author":"Faubion","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2017.04.026_b0060","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/cphy.c120020","article-title":"Apoptosis and necrosis in the liver","volume":"3","author":"Guicciardi","year":"2013","journal-title":"Compr Physiol"},{"key":"10.1016\/j.jhep.2017.04.026_b0065","doi-asserted-by":"crossref","first-page":"4985","DOI":"10.3748\/wjg.v18.i36.4985","article-title":"Novel insight into mechanisms of cholestatic liver injury","volume":"18","author":"Woolbright","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2017.04.026_b0070","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.taap.2015.01.015","article-title":"Bile acid-induced necrosis in primary human hepatocytes and in patients with obstructive cholestasis","volume":"283","author":"Woolbright","year":"2015","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.jhep.2017.04.026_b0075","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1053\/gast.2002.35948","article-title":"Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles","volume":"123","author":"Fickert","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2017.04.026_b0080","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.jhep.2004.10.016","article-title":"Oncosis represents the main type of cell death in mouse models of cholestasis","volume":"42","author":"Fickert","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2017.04.026_b0085","doi-asserted-by":"crossref","first-page":"410","DOI":"10.2353\/ajpath.2006.050404","article-title":"Lithocholic acid feeding induces segmental bile duct obstruction and destructive cholangitis in mice","volume":"168","author":"Fickert","year":"2006","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jhep.2017.04.026_b0090","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1152\/physrev.00061.2009","article-title":"Hepatocyte death: a clear and present danger","volume":"90","author":"Malhi","year":"2010","journal-title":"Physiol Rev"},{"key":"10.1016\/j.jhep.2017.04.026_b0095","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jhep.2014.11.027","article-title":"Autophagy and senescence in fibrosing cholangiopathies","volume":"62","author":"Nakanuma","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2017.04.026_b0100","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.ajpath.2014.10.027","article-title":"Functional role of cellular senescence in biliary injury","volume":"185","author":"Meng","year":"2015","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jhep.2017.04.026_b0105","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1002\/hep.26993","article-title":"Cholangiocyte senescence by way of N-ras activation is a characteristic of primary sclerosing cholangitis","volume":"59","author":"Tabibian","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2017.04.026_b0110","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1159\/000445268","article-title":"Farnesoid X receptor agonists and other bile acid signaling strategies for treatment of liver disease","volume":"34","author":"Halilbasic","year":"2016","journal-title":"Dig Dis"},{"key":"10.1016\/j.jhep.2017.04.026_b0115","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/0092-8674(93)90380-9","article-title":"Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease","volume":"75","author":"Smit","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.jhep.2017.04.026_b0120","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jaut.2013.06.013","article-title":"Mucosal immunity in liver autoimmunity: a comprehensive review","volume":"46","author":"Trivedi","year":"2013","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jhep.2017.04.026_b0125","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/cmi.2016.4","article-title":"Adaptive immunity in the liver","volume":"13","author":"Shuai","year":"2016","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.jhep.2017.04.026_b0130","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jaut.2015.07.004","article-title":"The immunogenetics of primary biliary cirrhosis: A comprehensive review","volume":"64","author":"Webb","year":"2015","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jhep.2017.04.026_b0135","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cld.2015.08.002","article-title":"The immunogenetics of autoimmune cholestasis","volume":"20","author":"Trivedi","year":"2016","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jhep.2017.04.026_b0140","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0140-6736(02)07374-9","article-title":"Homing of mucosal lymphocytes to the liver in the pathogenesis of hepatic complications of inflammatory bowel disease","volume":"359","author":"Grant","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2017.04.026_b0145","doi-asserted-by":"crossref","first-page":"e25718","DOI":"10.4161\/tisb.25718","article-title":"Bile duct epithelial tight junctions and barrier function","volume":"1","author":"Rao","year":"2013","journal-title":"Tissue Barriers"},{"key":"10.1016\/j.jhep.2017.04.026_b0150","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.mam.2013.10.001","article-title":"Chronic cholestatic liver diseases: clues from histopathology for pathogenesis","volume":"37","author":"Pollheimer","year":"2014","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.jhep.2017.04.026_b0155","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1194\/jlr.R049437","article-title":"Key discoveries in bile acid chemistry and biology and their clinical applications: history of the last eight decades","volume":"55","author":"Hofmann","year":"2014","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jhep.2017.04.026_b0160","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1002\/hep.22789","article-title":"Bile acids: trying to understand their chemistry and biology with the hope of helping patients","volume":"49","author":"Hofmann","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2017.04.026_b0165","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1007\/s00018-008-7568-6","article-title":"Bile acids: chemistry, pathochemistry, biology, pathobiology, and therapeutics","volume":"65","author":"Hofmann","year":"2008","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.jhep.2017.04.026_b0170","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.apsb.2015.01.001","article-title":"Metabolic effects of intestinal absorption and enterohepatic cycling of bile acids","volume":"5","author":"Ferrebee","year":"2015","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.jhep.2017.04.026_b0175","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nrm3312","article-title":"Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR","volume":"13","author":"Calkin","year":"2012","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.jhep.2017.04.026_b0180","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/S0022-2275(20)34421-7","article-title":"Physicochemical properties of bile acids and their relationship to biological properties: an overview of the problem","volume":"25","author":"Hofmann","year":"1984","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jhep.2017.04.026_b0185","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1081\/DMR-200033475","article-title":"Detoxification of lithocholic acid, a toxic bile acid: relevance to drug hepatotoxicity","volume":"36","author":"Hofmann","year":"2004","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.jhep.2017.04.026_b0190","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/S2210-7401(12)70018-9","article-title":"Progressive familial intrahepatic cholestasis","volume":"36","author":"Jacquemin","year":"2012","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.jhep.2017.04.026_b0195","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1055\/s-0030-1253221","article-title":"Progressive familial intrahepatic cholestasis type 1","volume":"30","author":"Paulusma","year":"2010","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2017.04.026_b0200","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.cld.2012.12.004","article-title":"Alagille syndrome and other hereditary causes of cholestasis","volume":"17","author":"Hartley","year":"2013","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jhep.2017.04.026_b0205","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.cld.2012.12.002","article-title":"Genetic determinants of cholestasis","volume":"17","author":"Hirschfield","year":"2013","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jhep.2017.04.026_b0210","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-0031-1272831","article-title":"Progressive familial intrahepatic cholestasis (PFIC) type 1, 2, and 3: a review of the liver pathology findings","volume":"31","author":"Morotti","year":"2011","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2017.04.026_b0215","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/hep.27240","article-title":"Sodium taurocholate cotransporting polypeptide (SLC10A1) deficiency: conjugated hypercholanemia without a clear clinical phenotype","volume":"61","author":"Vaz","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2017.04.026_b0220","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.jpeds.2007.02.030","article-title":"Mutations in bile salt export pump (ABCB11) in two children with progressive familial intrahepatic cholestasis and cholangiocarcinoma","volume":"150","author":"Scheimann","year":"2007","journal-title":"J Pediatr"},{"key":"10.1016\/j.jhep.2017.04.026_b0225","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1053\/j.gastro.2008.01.038","article-title":"Severe bile salt export pump deficiency: 82 different ABCB11 mutations in 109 families","volume":"134","author":"Strautnieks","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2017.04.026_b0230","doi-asserted-by":"crossref","first-page":"10713","DOI":"10.1038\/ncomms10713","article-title":"Mutations in the nuclear bile acid receptor FXR cause progressive familial intrahepatic cholestasis","volume":"7","author":"Gomez-Ospina","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2017.04.026_b0235","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1053\/j.gastro.2005.08.052","article-title":"Hepatocanalicular transport defects: pathophysiologic mechanisms of rare diseases","volume":"130","author":"Oude Elferink","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2017.04.026_b0240","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1053\/gast.2001.23984","article-title":"The wide spectrum of multidrug resistance 3 deficiency: from neonatal cholestasis to cirrhosis of adulthood","volume":"120","author":"Jacquemin","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2017.04.026_b0245","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1053\/j.gastro.2013.02.004","article-title":"Genetic defects in bile acid conjugation cause fat-soluble vitamin deficiency","volume":"144","author":"Setchell","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2017.04.026_b0250","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0168-8278(03)00096-5","article-title":"Adaptive changes in hepatobiliary transporter expression in primary biliary cirrhosis","volume":"38","author":"Zollner","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2017.04.026_b0255","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1053\/jhep.2001.22646","article-title":"Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases","volume":"33","author":"Zollner","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2017.04.026_b0260","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1056\/NEJMoa0901075","article-title":"Recurrence of bile salt export pump deficiency after liver transplantation","volume":"361","author":"Jara","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2017.04.026_b0265","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/lt.22074","article-title":"Recurrent low gamma-glutamyl transpeptidase cholestasis following liver transplantation for bile salt export pump (BSEP) disease (posttransplant recurrent BSEP disease)","volume":"16","author":"Siebold","year":"2010","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2017.04.026_b0270","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/hep.23083","article-title":"De novo bile salt transporter antibodies as a possible cause of recurrent graft failure after liver transplantation: a novel mechanism of cholestasis","volume":"50","author":"Keitel","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2017.04.026_b0275","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s12016-014-8457-4","article-title":"Autoimmune BSEP disease: disease recurrence after liver transplantation for progressive familial intrahepatic cholestasis","volume":"48","author":"Kubitz","year":"2015","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jhep.2017.04.026_b0280","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0005-2760(75)90143-5","article-title":"The intermicellar bile salt concentration in equilibrium with the mixed-micelles of human bile","volume":"398","author":"Duane","year":"1975","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jhep.2017.04.026_b0285","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jchromb.2007.09.031","article-title":"High-performance liquid chromatography-tandem mass spectrometry for the analysis of bile acid profiles in serum of women with intrahepatic cholestasis of pregnancy","volume":"860","author":"Ye","year":"2007","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.jhep.2017.04.026_b0290","doi-asserted-by":"crossref","unstructured":"Hofmann AF. Enterohepatic Circulation of Bile Acids. Compr Physiol 2011, Supplement 18: Handbook of Physiology, The Gastrointestinal System, Salivary, Gastric, Pancreatic, and Hepatobiliary Secretion: 567-596. First published in print 1989. 2011.","DOI":"10.1002\/cphy.cp060329"},{"key":"10.1016\/j.jhep.2017.04.026_b0295","doi-asserted-by":"crossref","first-page":"e22094","DOI":"10.1371\/journal.pone.0022094","article-title":"Profiling circulating and urinary bile acids in patients with biliary obstruction before and after biliary stenting","volume":"6","author":"Trottier","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2017.04.026_b0300","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.jhep.2013.01.003","article-title":"Modulation of the fecal bile acid profile by gut microbiota in cirrhosis","volume":"58","author":"Kakiyama","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2017.04.026_b0305","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0009-8981(96)06305-X","article-title":"Hepatic levels of bile acids in end-stage chronic cholestatic liver disease","volume":"251","author":"Fischer","year":"1996","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jhep.2017.04.026_b0310","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S0016-5085(97)70239-7","article-title":"Bile acid concentrations in human and rat liver tissue and in hepatocyte nuclei","volume":"112","author":"Setchell","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2017.04.026_b0315","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/MEG.0b013e3282f4710a","article-title":"Bile acid levels are increased in the liver of patients with steatohepatitis","volume":"20","author":"Aranha","year":"2008","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2017.04.026_b0320","doi-asserted-by":"crossref","first-page":"5454","DOI":"10.3748\/wjg.v19.i33.5454","article-title":"Biliary phosphatidylcholine and lysophosphatidylcholine profiles in sclerosing cholangitis","volume":"19","author":"Gauss","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2017.04.026_b0325","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jhep.2012.02.014","article-title":"Effect of ursodeoxycholic acid on bile acid profiles and intestinal detoxification machinery in primary biliary cirrhosis and health","volume":"57","author":"Dilger","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2017.04.026_b0330","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1067\/msy.2003.142","article-title":"Biliary bile acid concentration is a simple and reliable indicator for liver function after hepatobiliary resection for biliary cancer","volume":"133","author":"Kurumiya","year":"2003","journal-title":"Surgery"},{"key":"10.1016\/j.jhep.2017.04.026_b0335","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1111\/liv.13092","article-title":"Elevated interleukin-8 in bile of patients with primary sclerosing cholangitis","volume":"36","author":"Zweers","year":"2016","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2017.04.026_b0340","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/hep.24691","article-title":"A biliary HCO3- umbrella constitutes a protective mechanism against bile acid-induced injury in human cholangiocytes","volume":"55","author":"Hohenester","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2017.04.026_b0345","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/hep.27694","article-title":"Impaired uptake of conjugated bile acids and hepatitis b virus pres1-binding in na(+) -taurocholate cotransporting polypeptide knockout mice","volume":"62","author":"Slijepcevic","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2017.04.026_b0350","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1053\/gast.2001.25542","article-title":"Effects of ursodeoxycholic and cholic acid feeding on hepatocellular transporter expression in mouse liver","volume":"121","author":"Fickert","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2017.04.026_b0355","doi-asserted-by":"crossref","first-page":"e8984","DOI":"10.1371\/journal.pone.0008984","article-title":"Strain background modifies phenotypes in the ATP8B1-deficient mouse","volume":"5","author":"Shah","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2017.04.026_b0360","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/hep.1840400431","article-title":"Reduced oncotic necrosis in Fas receptor-deficient C57BL\/6J-lpr mice after bile duct ligation","volume":"40","author":"Gujral","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2017.04.026_b0365","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ajpath.2014.10.013","article-title":"A new Mdr2(\u2212\/\u2212) mouse model of sclerosing cholangitis with rapid fibrosis progression, early-onset portal hypertension, and liver cancer","volume":"185","author":"Ikenaga","year":"2015","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jhep.2017.04.026_b0370","doi-asserted-by":"crossref","first-page":"292","DOI":"10.4161\/gmic.24706","article-title":"Gut microbiota, tight junction protein expression, intestinal resistance, bacterial translocation and mortality following cholestasis depend on the genetic background of the host","volume":"4","author":"Alaish","year":"2013","journal-title":"Gut Microbes"},{"key":"10.1016\/j.jhep.2017.04.026_b0375","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0378-4274(92)90156-E","article-title":"Comparative hepatotoxicity of cholic acid, deoxycholic acid and lithocholic acid in the rat: in vivo and in vitro studies","volume":"61","author":"Delzenne","year":"1992","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.jhep.2017.04.026_b0380","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0092-8674(00)00062-3","article-title":"Targeted disruption of the nuclear receptor FXR\/BAR impairs bile acid and lipid homeostasis","volume":"102","author":"Sinal","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.jhep.2017.04.026_b0385","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.toxlet.2014.04.001","article-title":"Lithocholic acid feeding results in direct hepato-toxicity independent of neutrophil function in mice","volume":"228","author":"Woolbright","year":"2014","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.jhep.2017.04.026_b0390","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1053\/gast.1996.v111.pm8698195","article-title":"Effects of Ursodeoxycholate and cholate feeding on liver disease in FVB mice with a disrupted mdr2 P-glycoprotein gene","volume":"111","author":"Van Nieuwkerk","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2017.04.026_b0395","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/hep.21212","article-title":"Atp8b1 deficiency in mice reduces resistance of the canalicular membrane to hydrophobic bile salts and impairs bile salt transport","volume":"44","author":"Paulusma","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2017.04.026_b0400","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1053\/j.gastro.2004.04.009","article-title":"Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice","volume":"127","author":"Fickert","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2017.04.026_b0405","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1053\/j.gastro.2005.10.018","article-title":"24-norUrsodeoxycholic acid is superior to ursodeoxycholic acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout mice","volume":"130","author":"Fickert","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2017.04.026_b0410","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/hep.27973","article-title":"Pharmacological inhibition of apical sodium-dependent bile acid transporter changes bile composition and blocks progression of sclerosing cholangitis in multidrug resistance 2 knockout mice","volume":"63","author":"Miethke","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2017.04.026_b0415","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.jhep.2015.10.024","article-title":"Inhibition of intestinal bile acid absorption improves cholestatic liver and bile duct injury in a mouse model of sclerosing cholangitis","volume":"64","author":"Baghdasaryan","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2017.04.026_b0420","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1124\/jpet.113.209353","article-title":"All-trans-retinoic acid improves cholestasis in alpha-naphthylisothiocyanate-treated rats and Mdr2-\/- mice","volume":"349","author":"Cai","year":"2014","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jhep.2017.04.026_b0425","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/hep.28257","article-title":"Engineered fibroblast growth factor 19 reduces liver injury and resolves sclerosing cholangitis in Mdr2-deficient mice","volume":"63","author":"Zhou","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2017.04.026_b0430","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1476-511X-6-3","article-title":"Primary sclerosing cholangitis\u2013the arteriosclerosis of the bile duct?","volume":"6","author":"Fickert","year":"2007","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.jhep.2017.04.026_b0435","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1073\/pnas.98.4.2011","article-title":"Targeted inactivation of sister of P-glycoprotein gene (spgp) in mice results in nonprogressive but persistent intrahepatic cholestasis","volume":"98","author":"Wang","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2017.04.026_b0440","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1053\/jhep.2003.09037","article-title":"Severe cholestasis induced by cholic acid feeding in knockout mice of sister of P-glycoprotein","volume":"38","author":"Wang","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2017.04.026_b0445","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1002\/hep.23089","article-title":"Compensatory role of P-glycoproteins in knockout mice lacking the bile salt export pump","volume":"50","author":"Wang","year":"2009","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.jhep.2017.04.026_b0450","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jhep.2016.08.017","article-title":"Metabolic preconditioning protects BSEP\/ABCB11\u2212\/\u2212 mice against cholestatic liver injury","volume":"66","author":"Fuchs","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2017.04.026_b0455","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1073\/pnas.1322731111","article-title":"Loss of liver E-cadherin induces sclerosing cholangitis and promotes carcinogenesis","volume":"111","author":"Nakagawa","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2017.04.026_b0460","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1002\/hep.23801","article-title":"Liver-specific beta-catenin knockout mice have bile canalicular abnormalities, bile secretory defect, and intrahepatic cholestasis","volume":"52","author":"Yeh","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2017.04.026_b0465","doi-asserted-by":"crossref","first-page":"6835","DOI":"10.1038\/srep06835","article-title":"Loss of alpha-catenin elicits a cholestatic response and impairs liver regeneration","volume":"4","author":"Herr","year":"2014","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhep.2017.04.026_b0470","doi-asserted-by":"crossref","first-page":"e1110","DOI":"10.1053\/j.gastro.2014.07.033","article-title":"Claudin 2 deficiency reduces bile flow and increases susceptibility to cholesterol gallstone disease in mice","volume":"147","author":"Matsumoto","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2017.04.026_b0475","doi-asserted-by":"crossref","first-page":"e23495","DOI":"10.4161\/tisb.23495","article-title":"Role of grainyhead-like 2 in the formation of functional tight junctions","volume":"1","author":"Tanimizu","year":"2013","journal-title":"Tissue Barriers"},{"key":"10.1016\/j.jhep.2017.04.026_b0480","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1172\/JCI116546","article-title":"Glycochenodeoxycholate-induced lethal hepatocellular injury in rat hepatocytes. Role of ATP depletion and cytosolic free calcium","volume":"92","author":"Spivey","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2017.04.026_b0485","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1172\/JCI117579","article-title":"Increases of intracellular magnesium promote glycodeoxycholate-induced apoptosis in rat hepatocytes","volume":"94","author":"Patel","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2017.04.026_b0490","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/toxsci\/65.2.166","article-title":"Mechanisms of hepatotoxicity","volume":"65","author":"Jaeschke","year":"2002","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.jhep.2017.04.026_b0495","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1074\/jbc.M804585200","article-title":"Bile acid-induced apoptosis in hepatocytes is caspase-6-dependent","volume":"284","author":"Rust","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2017.04.026_b0500","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/hep.510260102","article-title":"Cytotoxicity of bile salts against biliary epithelium: a study in isolated bile ductule fragments and isolated perfused rat liver","volume":"26","author":"Benedetti","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2017.04.026_b0505","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.dld.2007.03.008","article-title":"Bile salts regulate proliferation and apoptosis of liver cells by modulating the IGF1 system","volume":"39","author":"Drudi Metalli","year":"2007","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jhep.2017.04.026_b0510","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/hep.27180","article-title":"Ursodeoxycholic acid in primary sclerosing cholangitis: if withdrawal is bad, then administration is good (right?)","volume":"60","author":"Tabibian","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2017.04.026_b0515","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/sj.cdd.4400560","article-title":"Ursodeoxycholic acid prevents cytochrome c release in apoptosis by inhibiting mitochondrial membrane depolarization and channel formation","volume":"6","author":"Rodrigues","year":"1999","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.jhep.2017.04.026_b0520","doi-asserted-by":"crossref","first-page":"G727","DOI":"10.1152\/ajpgi.00410.2001","article-title":"CAMP inhibits bile acid-induced apoptosis by blocking caspase activation and cytochrome c release","volume":"283","author":"Webster","year":"2002","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jhep.2017.04.026_b0525","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1053\/jhep.2003.50341","article-title":"Neutrophils aggravate acute liver injury during obstructive cholestasis in bile duct-ligated mice","volume":"38","author":"Gujral","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2017.04.026_b0530","doi-asserted-by":"crossref","first-page":"G499","DOI":"10.1152\/ajpgi.00318.2003","article-title":"Functional importance of ICAM-1 in the mechanism of neutrophil-induced liver injury in bile duct-ligated mice","volume":"286","author":"Gujral","year":"2004","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jhep.2017.04.026_b0535","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.toxlet.2013.10.030","article-title":"Osteopontin is an initial mediator of inflammation and liver injury during obstructive cholestasis after bile duct ligation in mice","volume":"224","author":"Yang","year":"2014","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.jhep.2017.04.026_b0540","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ajpath.2010.11.026","article-title":"Bile acids induce inflammatory genes in hepatocytes: a novel mechanism of inflammation during obstructive cholestasis","volume":"178","author":"Allen","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jhep.2017.04.026_b0545","doi-asserted-by":"crossref","first-page":"e93567","DOI":"10.1371\/journal.pone.0093567","article-title":"GPBAR1\/TGR5 mediates bile acid-induced cytokine expression in murine Kupffer cells","volume":"9","author":"Lou","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2017.04.026_b0550","doi-asserted-by":"crossref","first-page":"21805","DOI":"10.1074\/jbc.C000275200","article-title":"Bile acid induction of cytokine expression by macrophages correlates with repression of hepatic cholesterol 7alpha-hydroxylase","volume":"275","author":"Miyake","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2017.04.026_b0555","series-title":"Steros and Bile Acids","first-page":"345","article-title":"Physcio-chemical properties of bile acids and their salts","author":"Carey","year":"1985"},{"key":"10.1016\/j.jhep.2017.04.026_b0560","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/0016-5085(94)90083-3","article-title":"Protective role of biliary cholesterol and phospholipid lamellae against bile acid-induced cell damage","volume":"107","author":"Puglielli","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2017.04.026_b0565","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1002\/hep.23810","article-title":"The biliary HCO(3)(\u2212) umbrella: a unifying hypothesis on pathogenetic and therapeutic aspects of fibrosing cholangiopathies","volume":"52","author":"Beuers","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2017.04.026_b0570","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/MOG.0b013e328352aab2","article-title":"The biliary HCO(3)(\u2212) umbrella: experimental evidence revisited","volume":"28","author":"Beuers","year":"2012","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.jhep.2017.04.026_b0575","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/hep.28550","article-title":"Soluble adenylyl cyclase regulates bile salt-induced apoptosis in human cholangiocytes","volume":"64","author":"Chang","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2017.04.026_b0580","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1053\/j.gastro.2008.02.020","article-title":"Ae2a, b-deficient mice develop antimitochondrial antibodies and other features resembling primary biliary cirrhosis","volume":"134","author":"Salas","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2017.04.026_b0585","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1002\/hep.510260604","article-title":"Enhanced apoptosis relates to bile duct loss in primary biliary cirrhosis","volume":"26","author":"Harada","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2017.04.026_b0590","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1034\/j.1600-0676.2000.020002129.x","article-title":"Fas ligand expressing mononuclear cells around intrahepatic bile ducts co-express CD68 in primary biliary cirrhosis","volume":"20","author":"Iwata","year":"2000","journal-title":"Liver"},{"key":"10.1016\/j.jhep.2017.04.026_b0595","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/hep.510250505","article-title":"Nuclear DNA fragmentation and expression of Bcl-2 in primary biliary cirrhosis","volume":"25","author":"Koga","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2017.04.026_b0600","doi-asserted-by":"crossref","first-page":"3642","DOI":"10.1007\/s10620-015-3805-7","article-title":"Individuals with primary sclerosing cholangitis have elevated levels of biomarkers for apoptosis but not necrosis","volume":"60","author":"Masuoka","year":"2015","journal-title":"Dig Dis Sci"},{"issue":"2","key":"10.1016\/j.jhep.2017.04.026_b0605","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3727\/105221616X692991","article-title":"Bile duct ligation induces Atz globule clearance in a mouse model of alpha-1 antitrypsin deficiency","volume":"17","author":"Khan","year":"2017","journal-title":"Gene Expr"},{"key":"10.1016\/j.jhep.2017.04.026_b0610","first-page":"205128","article-title":"Biliary epithelial apoptosis, autophagy, and senescence in primary biliary cirrhosis","volume":"2010","author":"Sasaki","year":"2010","journal-title":"Hepat Res Treat"},{"key":"10.1016\/j.jhep.2017.04.026_b0615","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nature13961","article-title":"Nutrient-sensing nuclear receptors coordinate autophagy","volume":"516","author":"Lee","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2017.04.026_b0620","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/labinvest.2010.56","article-title":"Autophagy mediates the process of cellular senescence characterizing bile duct damages in primary biliary cirrhosis","volume":"90","author":"Sasaki","year":"2010","journal-title":"Lab Invest"},{"key":"10.1016\/j.jhep.2017.04.026_b0625","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/01.LAB.0000069036.63405.5C","article-title":"Apoptotic body engulfment by a human stellate cell line is profibrogenic","volume":"83","author":"Canbay","year":"2003","journal-title":"Lab Invest"},{"issue":"3","key":"10.1016\/j.jhep.2017.04.026_b0630","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/hep.28622","article-title":"The secretin\/secretin receptor axis modulates liver fibrosis through changes in transforming growth factor-\u03b21 biliary secretion in mice","volume":"64","author":"Wu","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2017.04.026_b0635","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.tox.2008.06.013","article-title":"Hepatic fibrosis \u2013 overview","volume":"254","author":"Friedman","year":"2008","journal-title":"Toxicology"},{"key":"10.1016\/j.jhep.2017.04.026_b0640","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1136\/gut.50.6.891","article-title":"Transcriptional regulation of hepatic stellate cell activation","volume":"50","author":"Mann","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2017.04.026_b0645","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1053\/j.gastro.2004.08.001","article-title":"The nuclear receptor SHP mediates inhibition of hepatic stellate cells by FXR and protects against liver fibrosis","volume":"127","author":"Fiorucci","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2017.04.026_b0650","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1124\/jpet.105.085597","article-title":"Cross-talk between farnesoid-X-receptor (FXR) and peroxisome proliferator-activated receptor gamma contributes to the antifibrotic activity of FXR ligands in rodent models of liver cirrhosis","volume":"315","author":"Fiorucci","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jhep.2017.04.026_b0655","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1124\/jpet.105.084905","article-title":"A farnesoid x receptor-small heterodimer partner regulatory cascade modulates tissue metalloproteinase inhibitor-1 and matrix metalloprotease expression in hepatic stellate cells and promotes resolution of liver fibrosis","volume":"314","author":"Fiorucci","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"issue":"6","key":"10.1016\/j.jhep.2017.04.026_b0660","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.2353\/ajpath.2009.090114","article-title":"Farnesoid X receptor critically determines the fibrotic response in mice but is expressed to a low extent in human hepatic stellate cells and periductal myofibroblasts","volume":"175","author":"Fickert","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jhep.2017.04.026_b0665","doi-asserted-by":"crossref","first-page":"33453","DOI":"10.1038\/srep33453","article-title":"FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis","volume":"6","author":"Verbeke","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhep.2017.04.026_b0670","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1002\/hep.26939","article-title":"Obeticholic acid, a farnesoid X receptor agonist, improves portal hypertension by two distinct pathways in cirrhotic rats","volume":"59","author":"Verbeke","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2017.04.026_b0675","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.clinre.2014.07.007","article-title":"Shaping macrophages function and innate immunity by bile acids: mechanisms and implication in cholestatic liver diseases","volume":"38","author":"Calmus","year":"2014","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.jhep.2017.04.026_b0680","doi-asserted-by":"crossref","unstructured":"Hofmann AF. Enterohepatic Circulation of Bile Acids. Compr Physiol 2011, Supplement 18: Handbook of Physiology, The Gastrointestinal System, Salivary, Gastric, Pancreatic, and Hepatobiliary Secretion: 567\u2013596. First published in print 1989.","DOI":"10.1002\/cphy.cp060329"},{"key":"10.1016\/j.jhep.2017.04.026_b0685","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1194\/jlr.M500427-JLR200","article-title":"Fxr(\u2212\/\u2212) mice adapt to biliary obstruction by enhanced phase I detoxification and renal elimination of bile acids","volume":"47","author":"Marschall","year":"2006","journal-title":"J Lipid Res"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827817320081?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827817320081?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T16:30:35Z","timestamp":1714581035000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827817320081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":137,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S0168827817320081"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2017.04.026","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biliary bile acids in hepatobiliary injury \u2013 What is the link?","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2017.04.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}